🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine whether 5-Azacytidine priming bef...
Status
Completed
Location
Weill Cornell Medical College
Start Date
2015-02-13
Trial ID
NCT02497404
Treatments Being Tested
This Phase II pilot study evaluates the safety and effectiveness of reduced...
Status
Completed
Location
The Children's Hospital of Philadelphia
Start Date
2008-01
Trial ID
NCT01050855
Treatments Being Tested
This is a standard of care treatment guideline for allogeneic hematopoetic ...
Status
Active Not Recruiting
Location
Masonic Cancer Center, University of Minnesota
Start Date
2012-09-04
Trial ID
NCT01652092
This study is being done to determine if blood cell transplants, with eithe...
Status
Completed
Location
Regents of University of California- UCLA
Start Date
2010-01
Trial ID
NCT01005576
Treatments Being Tested
This study is designed to estimate the efficacy and toxicity of familial HL...
Status
Recruiting
Location
Yale School of Medicine
Start Date
2017-03-20
Trial ID
NCT03128996
Treatments Being Tested
The purpose of this study is to determine the safety and toxicity and feasi...
Status
Terminated
Location
Columbia Presbyterian Medical Center
Start Date
2007-09-06
Trial ID
NCT00801931
This is a data collection study that will examine the general diagnostic an...
Status
Recruiting
Location
UPMC Children's Hospital of Pittsburgh
Start Date
2020-08-20
Trial ID
NCT04528355
Treatments Being Tested
Primary objective: * To determine the safety of adback T- or Natural Kille...
Status
Completed
Location
UT MD Anderson Cancer Center
Start Date
2007-09
Trial ID
NCT00536978
RATIONALE: Giving low doses of chemotherapy, monoclonal antibodies, and rad...
Status
Withdrawn
Location
Moores UCSD Cancer Center
Start Date
2006-05
Trial ID
NCT00085449
RATIONALE: Giving low doses of chemotherapy before a donor peripheral blood...
Status
Completed
Location
Yale Cancer Center
Start Date
2005-02
Trial ID
NCT00104975